Merck KGaA: TEPMETKO Receives CHMP Positive Opinion In Adult Patients With Advanced NSCLC
17/12 14:22
(RTTNews) - Merck KGaA (MKGAY.PK) announced the CHMP of the European Medicines Agency adopted a positive opinion recommending approval of once-daily oral TEPMETKO as monotherapy for the treatment of adult patients with advanced non-small cell lung cancer harboring alterations lea...